1. Home
  2. TMCI vs PSNYW Comparison

TMCI vs PSNYW Comparison

Compare TMCI & PSNYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMCI
  • PSNYW
  • Stock Information
  • Founded
  • TMCI 2014
  • PSNYW 2017
  • Country
  • TMCI United States
  • PSNYW Sweden
  • Employees
  • TMCI N/A
  • PSNYW 2547
  • Industry
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PSNYW Auto Manufacturing
  • Sector
  • TMCI Health Care
  • PSNYW Consumer Discretionary
  • Exchange
  • TMCI Nasdaq
  • PSNYW Nasdaq
  • Market Cap
  • TMCI 371.1M
  • PSNYW 316.6M
  • IPO Year
  • TMCI 2021
  • PSNYW N/A
  • Fundamental
  • Price
  • TMCI $5.53
  • PSNYW $0.15
  • Analyst Decision
  • TMCI Hold
  • PSNYW
  • Analyst Count
  • TMCI 6
  • PSNYW 0
  • Target Price
  • TMCI $9.18
  • PSNYW N/A
  • AVG Volume (30 Days)
  • TMCI 352.4K
  • PSNYW 43.4K
  • Earning Date
  • TMCI 08-05-2025
  • PSNYW 03-06-2025
  • Dividend Yield
  • TMCI N/A
  • PSNYW N/A
  • EPS Growth
  • TMCI N/A
  • PSNYW N/A
  • EPS
  • TMCI N/A
  • PSNYW N/A
  • Revenue
  • TMCI $210,819,000.00
  • PSNYW $2,034,261,000.00
  • Revenue This Year
  • TMCI $10.61
  • PSNYW N/A
  • Revenue Next Year
  • TMCI $10.36
  • PSNYW $79.49
  • P/E Ratio
  • TMCI N/A
  • PSNYW N/A
  • Revenue Growth
  • TMCI 7.54
  • PSNYW N/A
  • 52 Week Low
  • TMCI $4.54
  • PSNYW $0.09
  • 52 Week High
  • TMCI $10.79
  • PSNYW $0.61
  • Technical
  • Relative Strength Index (RSI)
  • TMCI 34.86
  • PSNYW 38.47
  • Support Level
  • TMCI $5.36
  • PSNYW $0.14
  • Resistance Level
  • TMCI $6.28
  • PSNYW $0.15
  • Average True Range (ATR)
  • TMCI 0.24
  • PSNYW 0.01
  • MACD
  • TMCI -0.00
  • PSNYW -0.00
  • Stochastic Oscillator
  • TMCI 16.30
  • PSNYW 12.86

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)

Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.

Share on Social Networks: